IP Verse

Method For Reducing The Occurrence Of Infection In Young Children - EP2723195

The patent EP2723195 was granted to Nutricia on Oct 24, 2018. The application was originally filed on Jun 22, 2012 under application number EP12732726A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2723195

NUTRICIA
Application Number
EP12732726A
Filing Date
Jun 22, 2012
Status
Opposition Rejected
Jan 19, 2024
Publication Date
Oct 24, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRESENIUS KABI DEUTSCHLANDJul 15, 2019FRESENIUS KABI DEUTSCHLAND -
NESTLEJul 10, 2019PLOUGMANN VINGTOFT -

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0171564
DESCRIPTIONWO2005122790
DESCRIPTIONWO2006022543
DESCRIPTIONWO2006115412
DESCRIPTIONWO2008054192
INTERNATIONAL-SEARCH-REPORTEP1714564
INTERNATIONAL-SEARCH-REPORTWO2005122791
INTERNATIONAL-SEARCH-REPORTWO2006022542
INTERNATIONAL-SEARCH-REPORTWO2006112716
INTERNATIONAL-SEARCH-REPORTWO2006112717
INTERNATIONAL-SEARCH-REPORTWO2007105945
INTERNATIONAL-SEARCH-REPORTWO2008054192
OPPOSITIONEP1714564
OPPOSITIONUS2010278781
OPPOSITIONUS5827526
OPPOSITIONWO2005122791
OPPOSITIONWO2006018314
OPPOSITIONWO2006022542
OPPOSITIONWO2007105945
OPPOSITIONWO2009157767

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Feeding the non-breastfed child 6-24 months of age", WHO/FCH/CAH/04.13 Meeting Report, (20040000), pages iii-iv, 1 - 6, XP055624734
OPPOSITION- Anonymous, "Interim Summary of Conclusions and Dietary Recommendations on Total Fat & Fatty Acids", Joint FAO/WHO Expert Consultation on Fats and Fatty acids in Human Nutrition, (20081100), pages 1 - 14, XP055624725
OPPOSITION- ARSLANOGLU et al., "Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life", The Journal of nutrition, (20080000), vol. 138, pages 1091 - 1095, XP055031734
OPPOSITION- ARSLANOGLU et al., "Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life", The Journal of Nutrition, (20070000), vol. 137, pages 2420 - 2424, XP002683144
OPPOSITION- BRUZZESE et al., "PN2-18 : Early Administration of GOS/FOS Prevents Intestinal and Respiratory Infections in Infants", J. Pediatr Gastroenterol Nutr, (20060000), vol. 42, no. 5, page E95, XP055624730
OPPOSITION- FDA, "Generally recognized as safe '' (GRAS) Exemption Claim for Galacto-oligosaccharides (GOS)", FDA, (20071018), pages 1 - 161, URL: http://wayback.archiveit.org/7993/20171031055401/https://www.fda.gov/downloads/Food/IngredientsPackagingLabeline/GRAS/NoticeInventory/UCM264094.pdf, XP055626234
OPPOSITION- Sridhar GANAPATHY, "Long Chain Polyunsaturated Fatty Acids and Immunity Infants", Indian Pediatrics, (20090917), vol. 46, pages 785 - 790, XP055624724
OPPOSITION- "Table 5-3 sources of Omega Fatty Acids", Eleanor Noss WHITNEY, Sharon Rady Rolfes, UNDERSTANDING NUTRITION, Seventh Edition, West Publishing company, (19960000), page 163, XP055624738
OPPOSITION- V. SHAW et al., "Clinical Paediatric Dietetics second edition", Clinical Paediatric Dietetics second edition, (20020000), pages 10 - 11, XP055626228
OPPOSITION- William C, Shiel Jr., "Medical Definition of Infection", (20181112), URL: https://www.medicinenet.com/script/main/art.asp?articlekey=12923
OPPOSITION- Bruzzese E; Volpicelli M; Squeglia V; Bruzzese D; Salvini F; Bisceglia M; Lionetti P; Cinquetti M; Iacono G; Amarri S; Guarino A, "A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: An observational study", CLINICAL NUTRITION,, (20090000), vol. 28, pages 156 - 161, XP026069003
OPPOSITION- VOS et al., "A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model", Int Immunopharmacol, (20060000), vol. 6, no. 8, pages 1277 - 1286, XP005507118
OPPOSITION- SHERMAN et al., "Potential Roles and Clinical Utility of Prebiotics in Newborns, Infants, and Children: Proceedings from a Global Prebiotic Summit Meeting, New York City, June 27-28, 2008", JOURNAL OF PEDIATRICS, (20090000), vol. 155, no. 5, pages S61 - S70, XP026696411
OPPOSITION- FABER et al., "Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia", British Journal of Cancer, (20080000), vol. 99, pages 2029 - 2036, XP055346869
OPPOSITION- Veereman-Wauters Gigi, "Application of prebiotics in infant foods", British Journal of Nutrition,, (20050000), vol. 93, no. Suppl. 1, pages S57 - S60, XP009096016
OPPOSITION- Undurti N DAS, "Do unsaturated fatty acids function as endogenous antibacterial and antiviral molecules?", Am J Clin Nutr, (20060000), vol. 83, no. 2, pages 390 - 391, XP055624720
OPPOSITION- GOTTRAND, "Long-Chain Polyunsaturated Fatty Acids Influence the Immune System of Infants 1-3", The Journal of Nutrition, (20080000), vol. 138, pages 1807S - 1812S, XP055624723
OPPOSITION- SANGWAN, V. et al., "Galactooligosaccharides: Novel Components of Designer Food", Journal of Food Science, (20110413), vol. 76, no. 4, doi:10.1111/j.1750-3841.2011.02131.x, pages R103 - R111, XP002682759
OPPOSITION- PIERRE et al., "Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice", Am J Physiol Lung Cell Mol Physiol, (20070000), vol. 292, no. 6, pages L1422 - L1431, XP055347345
OPPOSITION- KEMP, S., "Improving the nutrition of patients using Entera Fibre Plus", British Journal of Nursing, (19990000), vol. 8, no. 15, XP055626921

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents